Gastrointestinal side effects affect up to 40% of people beginning GLP-1 agonist therapy, with diarrhea ranking among the most frequently reported
However, investors may be concerned about the company's likelihood of bringing this drug to market quickly enough to capture a sizable customer base, given that many alternatives are already available or are rushing through development
Metabolic Syndrome: This cluster of conditions, including high blood pressure, insulin resistance, and excess belly fat, is often accompanied by elevated GGT
Personalized GLP-1 Therapy with PlexusDx for Mental Health Support The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes GLP1R, GIPR, FTO, and MC4R variants that relate to GLP-1 and related signaling pathways
Luckily, N-Acetylcysteine is able to be absorbed in the digestive tract, and can easily cross the cell membrane and is converted within the cell to glutathione